Overactive bladder (OAB) is a condition in which individuals have symptoms such as urinary frequency and urgency, nocturia (multiple urinary voids at night), and incontinence. This can become a huge emotional burden for women.
Usually, a combination of factors causes this condition, some possible causes include:
–Idiopathic: OAB may arise spontaneously, and the cause is not known
–Weak pelvic muscles: Due to stretching in pregnancy and childbirth
–Postmenopausal estrogen deficiency: Decreasing or falling estrogen levels in the blood after menopause can contribute to developing OAB
–Overweight: Being overweight puts extra pressure on the bladder and weakens the pelvic floor muscles.
–Alcohol, caffeine, and urinary tract infection can aggravate the condition.
The first line of treatment is lifestyle or behavioral changes. As we mentioned in our last post, if these initial efforts don’t help enough with the symptoms, additional treatments are available, such as therapy with oral pills. However, due to side effects, many OAB patients discontinue taking tablets and are left without treatment. Click here to read the current treatment guidelines for OAB and Inura’s solution to this unmet medical need!
Inura Medical AG is a Swiss start-up company developing an innovative patented urethral suppository for women, using an existing, approved drug with a well-known safety profile. It offers rescue therapy for a highly prevalent and disabling health disorder: overactive bladder syndrome (OAB). This product facilitates the effective penetration of drugs through the urethral mucosal lining, preventing this disease’s symptoms and reducing side effects.